Isabel Gordaliza-Alaguero

1 minute reading time

Dr. Isabel Gordaliza-Alaguero is a biomedical scientist and Regulatory Affairs professional with a strong motivation to translate laboratory innovations into practical solutions that improve patients’ lives. Since March 2025, she has been Head of Regulatory Affairs at LentiCure.

Isabel Gordaliza-Alaguero

  • Regulatory Affairs Manager at LentiCure since March 2025. 

  • Regulatory Affairs Officer for lentiviral gene therapies at Erasmus MC between 2022 and 2025. During her time at Erasmus MC, the lentiviral gene therapy for Pompe disease received the Orphan Designation from the European Medicines Agency (EMA).  

  • PhD researcher at the Institute for Research in Biomedicine (Barcelona, ​​Spain) between 2016 and 2021. During her PhD, she studied intracellular processes related to cellular recycling mechanisms known as autophagy, resulting in multiple scientific publications.

  • More information on LinkedIn

About Isabel Gordaliza-Alaguero

Isabel is a highly analytical and versatile professional with a passion for continuous learning and exploring new disciplines. Driven by the desire to create meaningful change, she focuses on transformative projects that have a lasting positive impact on society. She believes that teamwork and collaboration between all stakeholders are essential to solving complex societal challenges.